Animal models of benign airway stenosis: Advances in construction techniques, evaluation systems, and perspectives

Abstract

The incidence of benign airway stenosis (BAS) is on the rise, and current treatment options are associated with a significant risk of restenosis. Therefore, there is an urgent need to explore new and effective prevention and treatment methods. Animal models serve as essential tools for investigating disease mechanisms and assessing novel therapeutic strategies, and the scientific rigor of their construction and validation significantly impacts the reliability of research findings. This paper systematically reviews the research progress and evaluation systems of BAS animal models over the past decade, aiming to provide a robust foundation for the optimized construction of BAS models, intervention studies, and clinical translation. This effort is intended to facilitate the innovation and advancement in BAS prevention and treatment strategies.

Keywords

airway stenosis / animal models / benign airway stenosis / evaluation systems

References

[1] Wei JM, Chen Y, Feng TM, et al. miR-34c-5p inhibited fibroblast proliferation, differentiation and epithelial-mesenchymal transition in benign airway stenosis via MDMX/p53 pathway. Funct Integr Genomics. 2024; 24(2): 37.

[2] Yang ZY, Zhou XL, Pan WY, Zeng DX, Jiang JH. Clinical analysis of 32 cases of subglottic benign airway stenosis treated with montgomery T silicone stent. Can Respir J. 2024; 2024(1):2145560.

[3] Huang ZJ, Wei P, Gan LM, et al. Expression of histone deacetylase 2 in tracheal stenosis models and its relationship with tracheal granulation tissue proliferation. Exp Ther Med. 2021; 21(5): 444.

[4] Yang MY, Li H, Zhou YZ, Li H, Wei HF, Cheng QH. Airway collapse hinders recovery in bronchoscopy therapy for postintubation tracheal stenosis patients. EurArchOtorhinolaryngol. 2024; 281(6): 3061-3069.

[5] Pappal RB, Burruss CP, Witt MA, et al. Risk factors for developing subglottic and tracheal stenosis from the medical intensive care unit. Laryngoscope Investig Otolaryngol. 2023; 8(3): 699-707.

[6] Qiu XJ, Zhang J, Wang T, Pei YH, Xu M. Nonstent combination interventional therapy for treatment of benign cicatricial airway stenosis. Chin Med J. 2015; 128(16): 2154-2161.

[7] Kumar A, Asaf BB, Puri HV, Abdellateef A. Resection and anastomosis for benign tracheal stenosis: Single institution experience of 18 cases. Lung India. 2017; 34(5): 420-426.

[8] Chen DF, Chen Y, Zhong CH, Chen XB, Li SY. Long-term efficacy and safety of the Dumon stent for benign tracheal stenosis: a meta-analysis. J Thorac Dis. 2021; 13(1): 82-91.

[9] Lian TM, Liang C, Yu SY, et al. Bronchial balloon dilatation combined with cryotherapy for tuberculous cicatricial central airway stenosis, with Adobe Photoshop for the degree measurement: a multicenter, retrospective study. Heliyon. 2023; 9(11):e22326.

[10] Sachs N, Papaspyropoulos A, van Zomer- Ommen DD, et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 2019; 38(4):e100300.

[11] Vazquez-Armendariz AI, Tata PR. Recent advances in lung organoid development and applications in disease modeling. J Clin Invest. 2023; 133(22):e170500.

[12] Jiang SP, Lin BQ, Zhou XQ, et al. Airway organoid models as pivotal tools for unraveling molecular mechanisms and therapeutic targets in respiratory diseases: a literature review. Ther Clin Risk Manag. 2025; 21: 975-986.

[13] Matkovic Leko I, Schneider RT, Thimraj TA, et al. A distal lung organoid model to study interstitial lung disease, viral infection and human lung development. Nat Protoc. 2023; 18(7): 2283-2312.

[14] Srivastava SK, Foo GW, Aggarwal N, Chang MW. Organ-on-chip technology: opportunities and challenges. Biotechnol Notes. 2024; 5: 8-12.

[15] Artzy Schnirman A, Hobi N, Schneider-Daum N, Guenat OT, Lehr C-M, Sznitman J. Advanced in vitro lung-on-chip platforms for inhalation assays: from prospect to pipeline. Eur J Pharm Biopharm. 2019; 144: 11-17.

[16] Koceva H, Amiratashani M, Akbarimoghaddam P, et al. Deciphering respiratory viral infections by harnessing organ-on-chip technology to explore the gut–lung axis. Open Biol. 2025; 15(3):240231.

[17] Dichtl S, Posch W, Wilflingseder D. The breathtaking world of human respiratory in vitro models: investigating lung diseases and infections in 3D models, organoids, and lung-on-chip. Eur J Immunol. 2024; 54(3):e2250356.

[18] Fisher CR, Mba Medie F, Luu RJ, et al. A high-throughput, high-containment human primary epithelial airway organ-on-Chip platform for SARS-CoV-2 therapeutic screening. Cells. 2023; 12(22):2639.

[19] Auletta B, Chiolerio P, Cecconi G, et al. Tissue-engineered neuromuscular organoids. Commun Biol. 2025; 8(1): 1074.

[20] Norouzi S, Saveh Shemshaki N, Norouzi E, et al. Recent advances in biomaterials for tissue-engineered constructs: essential factors and engineering techniques. Mater Today Chem. 2024; 37: 102016.

[21] Davis RJ, Hillel AT. Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know? Transl Cancer Res. 2020; 9(3): 2108-2116.

[22] Carpenter DJ, Hamdi OA, Finberg AM, Daniero JJ. Laryngotracheal stenosis: mechanistic review. Head Neck. 2022; 44(8): 1948-1960.

[23] Horejs C. Organ chips, organoids and the animal testing conundrum. Nat Rev Mater. 2021; 6(5): 1-2.

[24] Françoise BS, Montagutelli X. Animal models are essential to biological research: issues and perspectives. Future Sci OA. 2015; 1(4):FSO63.

[25] Swearengen JR. Choosing the right animal model for infectious disease research. Animal Models Exp Med. 2018; 1(2): 100-108.

[26] Khalmuratova R, Kim YS, Kim DW, Shin HW. A differentiated epithelial layer graft improves fibrosis and survival in airway stenosis via IL-37. Allergy. 2024; 80(5): 1468-1472.

[27] Chen YL, Yang C, Miao YS, et al. Macrophage STING signaling promotes fibrosis in benign airway stenosis via an IL6-STAT3 pathway. Nat Commun. 2025; 16(1): 289.

[28] Fan YH, Li X, Fang X, et al. Antifibrotic role of Nintedanib in tracheal stenosis after a tracheal wound. Laryngoscope. 2021; 131(9): E2496-E2505.

[29] He CY, Li AM, Gu L, et al. Repression of Smad3 by silencing Robo1 attenuates epithelial-mesenchymal transition in tracheobronchial stenosis. Chin Med J. 2023; 136(17): 2125-2127.

[30] Liao JX, Gan YL, Peng MY, et al. GDF15 alleviates the progression of benign tracheobronchial stenosis by inhibiting epithelial-mesenchymal transition and inactivating fibroblasts. Exp Cell Res. 2022; 421(2):113410.

[31] Chen S, Zhang W, Ning YY, Dong YC, Li Q, Bai C. Establishment of a benign tracheal stenosis model in rats by nylon brush scraping induced mechanical injury. Chin J Respir Crit Care Med. 2019; 18(3): 265-270.

[32] Mizokami D, Araki K, Tanaka N, et al. Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model. Laryngoscope. 2015; 125(6): E210-E215.

[33] Kim JH, Ahn JJ, Jegal Y, et al. Rapid establishment of tracheal stenosis in pigs using endotracheal tube cuff overpressure and electrocautery. Curr Med Sci. 2021; 41(2): 329-335.

[34] Zhou ZQ, Su ZQ, Sun W, et al. Postintubation tracheal stenosis evaluated by endobronchial optical coherence tomography: a canine model study. Respiration. 2020; 99(6): 500-507.

[35] Li F, Li PP, Cai ZG, et al. Establishment of two canine models of benign airway stenosis and the effect of mitomycin C on airway stenosis. Int J Pediatr Otorhinolaryngol. 2022; 159:111205.

[36] Chen XB, Wang WH, Ye YS, et al. The wound healing of autologous regenerative factor on recurrent benign airway stenosis: a canine experimental and pilot study. Respiration. 2024; 103(3): 111-123.

[37] Zhang GY, Wang JM, Zeng YM. A modified rabbit model of tracheal stenosis and a household endoscope. More simplicity and accessibility. Acta Cir Bras. 2020; 35(11):e351104.

[38] Wistermayer P, Escalante D, McIlwain W, Rogers DJ. A randomized controlled trial of dexamethasone as a prophylactic treatment for subglottic stenosis in a rabbit model. Ann Otol Rhinol Laryngol. 2020; 130(2):3489420946773.

[39] Wang LH, Zhang J, Chen N, Zhang YY, Xu M, Yue YM. The pilot study of the effect of paclitaxel by local application on scar formation after airway injury inrabbits. Zhonghua Jie He He Hu Xi Za Zhi. 2013; 36(3): 202-206.

[40] Qin EY, Xu MP, Gan LM, et al. Erythromycin combined with corticosteroid reduced inflammation and modified trauma-induced tracheal stenosis in a rabbit model. Ther Adv Respir Dis. 2018; 12:1753466618773707.

[41] Wilson J, Utz E, Marvin K, Schwartz I, Johnson C, Gaudreau P. Rabbit model of consistently survivable subglottic stenosis using a modified brush technique. Int J Pediatr Otorhinolaryngol. 2020; 139:110474.

[42] Zhang J, Liu YH, Yang ZY, et al. The role of tracheal wall injury in the development of benign airway stenosis in rabbits. Sci Rep. 2023; 13(1):3144.

[43] Lin H, Ainiwaer M, Jiang Z, Wang Z, Liu J, Chen F. Comparative evaluation of mechanical injury methods for establishing stable tracheal stenosis animal models. Sci Rep. 2024; 14(1):2383.

[44] McIlwain WR, Wistermayer PR, Swiss TP, Marko ST, Ieronimakis NM, Rogers DJ. Reproducing severe acute subglottic stenosis in a rabbit model. Int J Pediatr Otorhinolaryngol. 2017; 103: 142-146.

[45] Lee JY, Son SJ, Choi SH, Cho DW. The healing effect of platelet-rich plasma (PRP) jelly in rabbits undergoing tracheal resection and anastomosis. In vivo (Athens, Greece). 2019; 33(1): 75-78.

[46] Aydogmus U, Topkara A, Akbulut M, et al. Effectiveness of palatal mucosa graft in surgical treatment of sub-glottic stenosis. Clin Exp Otorhinolaryngol. 2016; 9(4): 358-365.

[47] Lee HS, Kim SW, Oak C, et al. Rabbit model of tracheal stenosis using cylindrical diffuser. Lasers Surg Med. 2017; 49(4): 372-379.

[48] Schweiger C, Hart CK, Tabangin ME, et al. Development of a survival animal model for subglottic stenosis. Laryngoscope. 2018; 129(4): 989-994.

[49] Tubbs KJ, Silva RC, Ramirez HE, Castleman WL, Collins WO. A comparison of two methods of endoscopic dilation of acute subglottic stenosis using a ferret model. Laryngoscope. 2013; 123(1): 253-258.

[50] Niu F, Sun B, Yu Y, et al. SPP1-mediated crosstalk between macrophage and fibroblasts promotes benign airway stenosis. Arch Biochem Biophys. 2025; 774:110627.

[51] Luo L, Huang J, Chen D, et al. Airway basal stem cell-derived extracellular vesicles drive ECM remodeling and suppress fibroblasts activation via the miR-30a-5p/FAP axis in benign tracheal stenosis. J Adv Res. 2025.

[52] Huang CH, Lichtarge S, Fernandez D. Integrative whole slide image and spatial transcriptomics analysis with QuST and QuPath. NPJ Precis Oncol. 2025; 9(1):70.

[53] Bankhead P, Loughrey MB, Fernández JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017; 7(1):16878.

[54] Beeche C, Singh JP, Leader JK, et al. Super U-net: a modularized generalizable architecture. Pattern Recogn. 2022; 128:108669.

[55] Azad R, Aghdam EK, Rauland A, et al. Medical image segmentation review: the success of U-net. IEEE Trans Pattern Anal Mach Intell. 2024; 46(12): 10076-10095.

[56] Mohamady YK, Geudens V, De Fays C, et al. Computational fluid dynamics of small airway disease in chronic obstructive pulmonary disease. EBioMedicine. 2025; 114:105670.

[57] Schwab AD, Wyatt TA, Schanze OW, et al. Lung-delivered IL-10 mitigates Lung inflammation induced by repeated endotoxin exposures in male mice. Physiol Rep. 2025; 13(4):e70253.

[58] Vermaut A, Aerts G, Willems L, et al. Pulmonary arteriole narrowing in end-stage cystic fibrosis lungs occurs with and without small airway disease. J Cyst Fibros. 2025; 24(5): 946-953.

[59] Daneshpour Moghadam S, Maris B, Mokhtari A, Daffara C, Fiorini P. OCT in oncology and precision medicine: from nanoparticles to advanced technologies and AI. Bioengineering. 2025; 12(6):650.

[60] Xu Y, Soundararajan S, Randell SH, et al. In vivo assessment of airway wall compliance during inhalation injury response using anatomical optical coherence elastography. J Biomed Opt. 2025; 30(7):076001.

[61] Hou P, Chen H, Liang S, et al. Targeting fibroblast activation protein for molecular imaging of fibrotic remodeling in pulmonary arterial hypertension. J Nucl Med. 2025; 66(1): 98-103.

[62] Loiseau A, Marcoux GR, Maranda C, Bertrand N, Boisselier E. Animal models in eye research: focus on corneal pathologies. Int J Mol Sci. 2023; 24(23):16661.

[63] Milani Nejad N, Janssen PML. Small and large animal models in cardiac contraction research: advantages and disadvantages. PharmacolTher. 2014; 141(3): 235-249.

[64] Gonzalez LM, Moeser AJ, Blikslager AT. Porcine models of digestive disease: the future of large animal translational research. Transl Res. 2015; 166(1): 12-27.

[65] Cao Y, Chen QQ, Liu YN, Jin LB, Peng RY. Research progress on the construction and application of a diabetic zebrafish model. Int J Mol Sci. 2023; 24(6): 5195.

[66] Kheirallah AK, Miller S, Hall IP, Sayers I. Translating Lung Function Genome-Wide Association Study (GWAS) findings: new insights for lung biology. Adv Genet. 2016; 93: 57-145.

[67] Eleonore F. Animals in respiratory research. Int J Mol Sci. 2024; 25(5):2903.

[68] Tanner L, Single AB. Animal models reflecting chronic obstructive pulmonary disease and related respiratory disorders: translating pre-clinical data into clinical relevance. J Innate Immun. 2020; 12(3): 203-225.

[69] Ribitsch I, Baptista PM, LangeConsiglio A, et al. Large animal models in regenerative medicine and tissue engineering: to do or not to do. Front Bioeng Biotechnol. 2020; 8: 972.

[70] Fehrenbach H, Wagner C, Wegmann M. Airway remodeling in asthma: what really matters. Cell Tissue Res. 2017; 367(3): 551-569.

[71] Alessandrini F, Musiol S, Schneider E, Blanco Pérez F, Albrecht M. Mimicking antigen-driven asthma in rodent models-how close can we get? Front Immunol. 2020; 11:575936.

[72] Rydell-Törmänen K, Johnson JR. The applicability of mouse models to the study of human disease. Methods Mol Biol (Clifton, NJ). 2019; 1940: 3-22.

[73] Huang Z, Wang L, Zhang CX, et al. Biomechanical strength dependence on mammalian airway length. J Thorac Dis. 2021; 13(2): 918-926.

[74] Pulido L, Burgos D, García Morato J, Luna CM. Does animal model on ventilator-associated pneumonia reflect physiopathology of sepsis mechanisms in humans? Ann Transl Med. 2017; 5(22): 452.

[75] Kulkarni HS, Lee JS, Bastarache JA, et al. Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report. Am J Respir Cell Mol Biol. 2022; 66(2): e1-e14.

[76] Lukas M, Kolar M, Ryska O, et al. A novel postgraduate endoscopic course using a large animal model of secondary Crohn's disease stricture. Surg Endosc. 2021; 35(6): 1-6.

[77] Chen R, Pye JS, Li J, Little CB, Li JJ. Multiphasic scaffolds for the repair of osteochondral defects: outcomes of preclinical studies. Bioact Mater. 2023; 27: 505-545.

[78] Zong JB, He QW, Liu YX, Qiu M, Wu JH, Hu B. Advances in the development of biodegradable coronary stents: a translational perspective. Mater Today Bio. 2022; 16:100368.

[79] Maynard LH, Humbert O, Peterson CW, Kiem H. Genome editing in large animal models. Mol Ther. 2021; 29(11): 3140-3152.

[80] Hiratsuka T, Inomata M. A novel animal model of colonic stenosis to aid the development of new stents for colon strictures. Surg Endosc. 2021; 36(5): 1-8.

[81] Han MN, Kim JH, Choi SH. Evaluation of biomechanical properties and morphometric structures of the trachea in pigs and rabbits. In vivo (Athens, Greece). 2022; 36(4): 1718-1725.

[82] Kim JH, Choi JY, Yoon HY. A rabbit model of tracheal collapse for optimal self-expanding metal stents. J Vet Med Sci. 2023; 85(3): 386-392.

[83] Kamaruzaman NA, Kardia E, Kamaldin NA, Latahir AZ, Yahaya BH. The rabbit as a model for studying lung disease and stem cell therapy. Biomed Res Int. 2013; 2013:691830.

[84] Gelbard A, Francis DO, Sandulache VC, Simmons JC, Donovan DT, Ongkasuwan J. Causes and consequences of adult laryngotracheal stenosis. Laryngoscope. 2015; 125(5): 1137-1143.

[85] Ravikumar N, Ho E, Wagh A, Murgu S. The role of bronchoscopy in the multidisciplinary approach to benign tracheal stenosis. J Thorac Dis. 2023; 15(7): 3998-4015.

RIGHTS & PERMISSIONS

2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.